Vimarsana
Biggest News Aggregation in the World

Page 13 - Manager Marketing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manager Marketing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manager Marketing Today - Breaking & Trending Today

DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients - Vimarsana News

DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients

DGAP-News: Proen ... DGAP-News: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients vom 16.12.2020, 10:00 Uhr Bild: pixabay.com DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients 16.12.2020 / 10:00 The issuer is solely responsible for the content of this announcement. The latest consensus meeting of international experts i...

Proenkephalin (penKid(R)) Included in the ADQI Consensus Statements Publication as Functional Kidney Biomarker for the Management of AKI Patients - Vimarsana News

Proenkephalin (penKid(R)) Included in the ADQI Consensus Statements Publication as Functional Kidney Biomarker for the Management of AKI Patients

Press release content from Accesswire. The AP news staff was not involved in its creation. Proenkephalin (penKid(R)) Included in the ADQI Consensus Statements Publication as Functional Kidney Biomarker for the Management of AKI Patients December 16, 2020 GMT The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage and functional biomarkers together with clinical information for routine practice Proenkephalin (pen...

Source: apnews.com
DGAP-News: SphingoTec GmbH: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients - Vimarsana News

DGAP-News: SphingoTec GmbH: Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients

(1) DGAP-News: SphingoTec GmbH / Key word(s): Scientific publication/Statement Proenkephalin (penKid(R)) included in the ADQI consensus statements publication as functional kidney biomarker for the management of AKI patients 16.12.2020 / 10:00 The issuer is solely responsible for the content of this announcement. The latest consensus meeting of international experts in critical care and nephrology supports the use of novel biomarkers in the prevention and management of Acute Kidney Injury (AKI) The consensus recommends using a combination of damage and functional biomarkers together with c...